Defective pancreatic alpha and beta cell secretion in thyrotoxicosis

Am J Med Sci. 1985 Nov;290(5):179-84. doi: 10.1097/00000441-198511000-00001.

Abstract

Pancreatic alpha and beta cell hormone secretion was studied in 11 patients with thyrotoxicosis before and in 7 patients after thyroid function was normalized with either prophylthiouracil or methimazole and propranolol (R). All had IV arginine and IV glucose infusions. Forty control subjects had IV arginine; 21 had IV glucose tests. After arginine, untreated patient had blunted serum insulin at both 15 and 30 minutes (p less than 0.05, p less than 0.001) compared to control subjects, blunted glucagon at 30 minutes (p less than 0.05) and blunted glucose at both 15 and 30 minutes (p less than 0.001, p less than 0.01) compared to control subjects. After glucose, untreated patients had lower nadir glucagon than in the studies with both arginine and glucose infusions. These data document blunted glucagon, suppressed glucose and insulin peaks after arginine in thyrotoxicosis, indicate that both alpha and beta cell hormone secretion may be abnormal, and that the preferential abnormality follows protein rather than carbohydrate loading.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Arginine / metabolism
  • Blood Glucose / analysis
  • Child
  • Child, Preschool
  • Female
  • Glucagon / blood
  • Glucagon / metabolism
  • Glucose / metabolism
  • Graves Disease / blood
  • Graves Disease / drug therapy
  • Graves Disease / metabolism*
  • Growth Hormone / blood
  • Growth Hormone / metabolism
  • Humans
  • Insulin / blood
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / metabolism*
  • Male
  • Methimazole / therapeutic use
  • Middle Aged
  • Propranolol / therapeutic use
  • Propylthiouracil / therapeutic use

Substances

  • Blood Glucose
  • Insulin
  • Methimazole
  • Propylthiouracil
  • Growth Hormone
  • Glucagon
  • Arginine
  • Propranolol
  • Glucose